TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Researchers report that increasing the brain enzyme Pla2g2f protected several measures of brain health and memory in aging mice. Findings in human microglia also linked increased enzyme activity to fewer lipid droplets, but the work does not establish a treatment for people.
A Nature Neuroscience study reports that raising levels of the brain enzyme Pla2g2f protected aging mice against memory impairment and several biological changes associated with brain aging. The researchers also found that increasing the enzyme’s activity reduced lipid buildup in human microglia in laboratory experiments, but the results do not show that it can prevent cognitive decline or Alzheimer’s disease in people.
Researchers led by Cinzia Vicidomini and senior author Amar Sahay, affiliated with Mass General Brigham, the Harvard Stem Cell Institute and the Broad Institute, identified Pla2g2f while looking for genes activated in response to synapse loss in the hippocampus of mice. The hippocampus plays a central role in memory. Pla2g2f produces a secreted phospholipase, an enzyme whose role in the brain had not previously been established, the authors said.
The team reported that Pla2g2f levels rose in the hippocampus as mice aged and during brain inflammation. They also found higher levels in older adults with signs of Alzheimer’s pathology who remained cognitively resilient. That human observation is an association; it does not establish that the enzyme caused those individuals to retain cognitive abilities.
In aging mice, reducing Pla2g2f worsened several measures, including synapse loss, inflammation, lipid disruption and memory impairment. Increasing the enzyme protected against many of those changes and helped preserve memory. The researchers said raising Pla2g2f in middle-aged mice, before substantial cognitive decline, changed the course of age-related memory loss. In experiments with human microglia, increasing Pla2g2f activity reduced lipid droplets and cholesterol esters, which are features reported in microglia in Alzheimer’s disease.
A Possible Route to Cognitive Resilience
The findings point to a biological process that may help the aging brain resist some forms of damage. The researchers connect Pla2g2f with several processes at once: synapse maintenance, inflammation and lipid handling. Microglia are brain immune cells that help clear waste and support neurons; lipid buildup in these cells has been linked to impaired function. A factor that influences these systems could give researchers a way to investigate how resilience is maintained, rather than studying only mechanisms associated with decline.
The work could inform future research into age-related memory loss and diseases such as Alzheimer’s, for which aging is a major risk factor. But the evidence described in the study is preclinical: it includes experiments in mice and laboratory work involving human cells, not a clinical trial showing benefit in patients. No therapy, dose, or safe method for increasing Pla2g2f in people has been established.
As an affiliate, we earn on qualifying purchases.
How Researchers Found Pla2g2f
Age-related changes in the brain can involve loss of connections between neurons, altered lipid metabolism and persistent inflammation. The study focused on the hippocampus, where synapse loss is associated with memory decline, and asked which genes respond when synapses are lost. That approach led the team to Pla2g2f, a gene not previously known for a role in the brain.
The researchers used genetic and viral methods to lower or raise Pla2g2f in the brains of aging mice and compared the resulting changes. They also examined the enzyme’s activity in human microglia. The paper, titled An aging-sensitive secreted phospholipase confers neuroprotection and cognitive resilience, was published in Nature Neuroscience in 2026 (DOI: 10.1038/s41593-026-02465-z).
“The researchers said they sought to identify protective factors that contribute to cognitive resilience during aging.”
— Cinzia Vicidomini and Amar Sahay, the study’s lead and senior authors
cognitive health supplements for aging
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Human Benefit Remains Unproven
The study does not establish whether increasing Pla2g2f would preserve memory in people, prevent mild cognitive impairment, or reduce Alzheimer’s risk. The finding in older adults with Alzheimer’s pathology was an observation, while the intervention experiments were conducted in mice and human cells in the laboratory. The source material does not specify the size or demographic makeup of the human group, nor does it provide evidence from a clinical trial.
It also remains unclear how Pla2g2f could be raised safely in an aging human brain, what level of activity would be needed, and whether any effect would last or have unwanted consequences. The researchers describe therapy development as a possibility under investigation, not an available treatment.
As an affiliate, we earn on qualifying purchases.
Testing Safe Ways to Raise Enzyme
The research team says it is exploring ways to increase Pla2g2f levels safely in the aging brain and in Alzheimer’s disease. Further work would need to test how the enzyme acts, establish safety and determine whether the protective effects seen in preclinical experiments can be reproduced in people. Until those steps are completed, the findings should be treated as a research lead rather than a basis for patient care.
memory support supplements for seniors
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is Pla2g2f?
Pla2g2f is a gene that produces a secreted phospholipase, an enzyme the researchers studied for its role in the aging brain. The paper reports that its levels rose in the hippocampus during aging and inflammation.
Did the enzyme prevent memory decline in people?
No. The reported memory protection came from experiments in aging mice. Human findings included an association in older adults and laboratory experiments with human microglia, not a clinical test of memory or treatment.
What happened when researchers reduced Pla2g2f in mice?
Lowering Pla2g2f worsened several measures of brain aging, including synapse loss, inflammation, lipid changes and memory impairment, according to the study.
Could this lead to an Alzheimer’s treatment?
The study suggests a possible direction for research, but it does not establish a treatment. The authors say more work is needed to determine whether Pla2g2f can be increased safely and whether doing so would benefit patients.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
